Asthma Endotyping and Biomarkers in Childhood Asthma

Amelia Licari, Riccardo Castagnoli, Ilaria Brambilla, Alessia Marseglia, Maria Angela Tosca, Gian Luigi Marseglia, Giorgio Ciprandi

Research output: Contribution to journalReview article

Abstract

Childhood asthma represents a heterogeneous challenging disease, in particular in its severe forms. The identification of different asthma phenotypes has stimulated research in underlying molecular mechanisms, such as the endotypes, and paved the way to the search for related specific biomarkers, which may guide diagnosis, management, and predict response to treatment. A limited number of biomarkers are currently available in clinical practice in the pediatric population, mostly reflecting type 2-high airway inflammation. The identification of biomarkers of childhood asthma is an active area of research that holds a potential great clinical utility and may represent a step forward toward tailored management and therapy: the so-called Precision Medicine. The aim of the present review is to provide an updated overview of asthma endotyping, mostly focusing on novel noninvasive biomarkers in childhood asthma.

Original languageEnglish
Pages (from-to)44-55
Number of pages12
JournalPediatric, Allergy, Immunology, and Pulmonology
Volume31
Issue number2
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Asthma
Biomarkers
Precision Medicine
Research
Pediatrics
Inflammation
Phenotype
Therapeutics
Population

Cite this

Asthma Endotyping and Biomarkers in Childhood Asthma. / Licari, Amelia; Castagnoli, Riccardo; Brambilla, Ilaria; Marseglia, Alessia; Tosca, Maria Angela; Marseglia, Gian Luigi; Ciprandi, Giorgio.

In: Pediatric, Allergy, Immunology, and Pulmonology, Vol. 31, No. 2, 01.06.2018, p. 44-55.

Research output: Contribution to journalReview article

Licari, Amelia ; Castagnoli, Riccardo ; Brambilla, Ilaria ; Marseglia, Alessia ; Tosca, Maria Angela ; Marseglia, Gian Luigi ; Ciprandi, Giorgio. / Asthma Endotyping and Biomarkers in Childhood Asthma. In: Pediatric, Allergy, Immunology, and Pulmonology. 2018 ; Vol. 31, No. 2. pp. 44-55.
@article{62c306cd1b924767a40d2067ed31e49b,
title = "Asthma Endotyping and Biomarkers in Childhood Asthma",
abstract = "Childhood asthma represents a heterogeneous challenging disease, in particular in its severe forms. The identification of different asthma phenotypes has stimulated research in underlying molecular mechanisms, such as the endotypes, and paved the way to the search for related specific biomarkers, which may guide diagnosis, management, and predict response to treatment. A limited number of biomarkers are currently available in clinical practice in the pediatric population, mostly reflecting type 2-high airway inflammation. The identification of biomarkers of childhood asthma is an active area of research that holds a potential great clinical utility and may represent a step forward toward tailored management and therapy: the so-called Precision Medicine. The aim of the present review is to provide an updated overview of asthma endotyping, mostly focusing on novel noninvasive biomarkers in childhood asthma.",
author = "Amelia Licari and Riccardo Castagnoli and Ilaria Brambilla and Alessia Marseglia and Tosca, {Maria Angela} and Marseglia, {Gian Luigi} and Giorgio Ciprandi",
year = "2018",
month = "6",
day = "1",
doi = "10.1089/ped.2018.0886",
language = "English",
volume = "31",
pages = "44--55",
journal = "Pediatric, Allergy, Immunology, and Pulmonology",
issn = "2151-321X",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Asthma Endotyping and Biomarkers in Childhood Asthma

AU - Licari, Amelia

AU - Castagnoli, Riccardo

AU - Brambilla, Ilaria

AU - Marseglia, Alessia

AU - Tosca, Maria Angela

AU - Marseglia, Gian Luigi

AU - Ciprandi, Giorgio

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Childhood asthma represents a heterogeneous challenging disease, in particular in its severe forms. The identification of different asthma phenotypes has stimulated research in underlying molecular mechanisms, such as the endotypes, and paved the way to the search for related specific biomarkers, which may guide diagnosis, management, and predict response to treatment. A limited number of biomarkers are currently available in clinical practice in the pediatric population, mostly reflecting type 2-high airway inflammation. The identification of biomarkers of childhood asthma is an active area of research that holds a potential great clinical utility and may represent a step forward toward tailored management and therapy: the so-called Precision Medicine. The aim of the present review is to provide an updated overview of asthma endotyping, mostly focusing on novel noninvasive biomarkers in childhood asthma.

AB - Childhood asthma represents a heterogeneous challenging disease, in particular in its severe forms. The identification of different asthma phenotypes has stimulated research in underlying molecular mechanisms, such as the endotypes, and paved the way to the search for related specific biomarkers, which may guide diagnosis, management, and predict response to treatment. A limited number of biomarkers are currently available in clinical practice in the pediatric population, mostly reflecting type 2-high airway inflammation. The identification of biomarkers of childhood asthma is an active area of research that holds a potential great clinical utility and may represent a step forward toward tailored management and therapy: the so-called Precision Medicine. The aim of the present review is to provide an updated overview of asthma endotyping, mostly focusing on novel noninvasive biomarkers in childhood asthma.

U2 - 10.1089/ped.2018.0886

DO - 10.1089/ped.2018.0886

M3 - Review article

C2 - 30069422

VL - 31

SP - 44

EP - 55

JO - Pediatric, Allergy, Immunology, and Pulmonology

JF - Pediatric, Allergy, Immunology, and Pulmonology

SN - 2151-321X

IS - 2

ER -